Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.38 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1041996 | 0.89 | GABBR2 (0.36) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL17594925 | 0.87 | POLB (0.44) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL28469471 | 0.84 | ALDH1A1 (0.46) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL1039800 | 0.84 | HSP90AA1 (0.35) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL18802719 | 0.82 | GABRA1 (0.42) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL3620122 | 0.80 | CYP3A4 (0.41) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL29707205 | 0.80 | HTT (0.39) | GABRA1GABRB2POLBALDH1A1CYP1A2 | |
| SCHEMBL2293546 | 0.80 | HTT (0.39) | GABRA1GABRB2POLBALDH1A1CYP1A2 | |
| SCHEMBL1086377 | 0.80 | POLB (0.52) | GABRA1GABRB2POLBALDH1A1ALOX15 | |
| SCHEMBL4572705 | 0.80 | ALDH1A1 (0.39) | GABRA1GABRB2POLBALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240254150-A1 | CONFORMATIONALLY RESTRICTED SULFONATE BASED PHOSPHINE LIGANDS FOR HINDERED SUZUKI COUPLING REACTIONS | TCG GreenChem Inc. (US) | 2024-08-01 | — | — | US | claimed |
| US-20260114115-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2026-04-23 | — | — | US | disclosed |
| US-20260042791-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-12 | — | — | US | disclosed |
| CN-119859147-A | Compound and organic electroluminescent device | 三星电子株式会社 | 2025-04-22 | — | — | CN | disclosed |
| US-12281129-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-04-22 | — | — | US | disclosed |
| US-12250875-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-03-11 | — | — | US | disclosed |
| US-20240254150-A1 | CONFORMATIONALLY RESTRICTED SULFONATE BASED PHOSPHINE LIGANDS FOR HINDERED SUZUKI COUPLING REACTIONS | TCG GreenChem Inc. (US) | 2024-08-01 | — | — | US | disclosed |
| US-20240122061-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-04-11 | — | — | US | disclosed |
| US-11930699-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-03-12 | — | — | US | disclosed |
| US-11737349-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-22 | — | — | US | disclosed |
| EP-1758853-B1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | LILLY CO ELI (US) | 2010-01-20 | — | — | EP | disclosed |
| US-20080312232-A1 | Substituted amide derivatives and methods of use | AMGEN INC. (US) | 2008-12-18 | — | — | US | disclosed |
| EP-1881976-A1 | SUBSTITUTED AMIDE DERIVATIVES AS PROTEIN KINASE INHIBITORS | Amgen Inc., (US) | 2008-01-30 | — | — | EP | disclosed |
| US-20070249688-A1 | Glucagon Receptor Antagonists, Preparation and Therapeutic Uses | ELI LILLY AND COMPANY (US) | 2007-10-25 | — | — | US | disclosed |
| EP-1758853-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2007-03-07 | — | — | EP | disclosed |
| WO-2006116713-A1 | SUBSTITUTED AMIDE DERIVATIVES AS PROTEIN KINASE INHIBITORS | AMGEN INC. (US) | 2006-11-02 | — | — | WO | disclosed |
| WO-2005123668-A1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | ELI LILLY AND COMPANY (US) | 2005-12-29 | — | — | WO | disclosed |
| US-3988369-A | Process and reactant for halogenating organic compounds | PEARSON DONALD E | 1976-10-26 | — | — | US | disclosed |
| US-3972872-A | BACTERICIDE, ANIMAL FEED SUPPLEMENT | PFIZER INC. (US) | 1976-08-03 | — | — | US | disclosed |
| US-3933797-A | 6-[α-(ω-QUANIDINOALKANOYLAMIDO)ACYLAMIDO]PENICILLANIC ACIDS | PFIZER INC. (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240254150-A1 | CONFORMATIONALLY RESTRICTED SULFONATE BASED PHOSPHINE LIGANDS FOR HINDERED SUZUKI COUPLING REACTIONS | STS, PTPRS, PFKFB1 | GABRA1 1170/4885GABRB2 1347/4885POLB 1179/4885 |
| US-12250875-B2 | Organic electroluminescent materials and devices | L1CAM, SOD1, EPCAM | GABRA1 2515/4885GABRB2 2277/4885POLB 1748/4885 |
| US-20260114115-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | CCNL2, ARL1, TRMT1L | GABRA1 3970/4885GABRB2 4498/4885POLB 2172/4885 |
| US-12281129-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OSBP | GABRA1 3648/4885GABRB2 3920/4885POLB 1546/4885 |
| US-11737349-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OTC | GABRA1 4384/4885GABRB2 4127/4885POLB 1878/4885 |
| US-20080312232-A1 | Substituted amide derivatives and methods of use | HGF, HGFAC, MET | GABRA1 2699/4885GABRB2 2340/4885POLB 1063/4885 |
| US-20070249688-A1 | Glucagon Receptor Antagonists, Preparation and Therapeutic Uses | GLP1R, GCGR, GIPR | GABRA1 461/4885GABRB2 642/4885POLB 4801/4885 |
| US-20260042791-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRA1, MSL1 | GABRA1 820/4885GABRB2 1286/4885POLB 2997/4885 |
| US-11930699-B2 | Organic electroluminescent materials and devices | L1CAM, EPCAM, LEF1 | GABRA1 2164/4885GABRB2 1765/4885POLB 1413/4885 |
| US-20240122061-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, SOD1, EPCAM | GABRA1 2515/4885GABRB2 2277/4885POLB 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.